tradingkey.logo
tradingkey.logo
Search

Oric Pharmaceuticals Inc

ORIC
Add to Watchlist
11.070USD
-0.570-4.90%
Close 07-31 16:00ETQuotes delayed by 15 min
1.15BMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nextech Invest, Ltd.
6.92%
EcoR1 Capital, LLC
6.50%
Viking Global Investors LP
6.35%
VR Adviser, LLC
5.48%
BlackRock Institutional Trust Company, N.A.
4.91%
Other
69.84%
Shareholders
Shareholders
Proportion
Nextech Invest, Ltd.
6.92%
EcoR1 Capital, LLC
6.50%
Viking Global Investors LP
6.35%
VR Adviser, LLC
5.48%
BlackRock Institutional Trust Company, N.A.
4.91%
Other
69.84%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
35.47%
Investment Advisor
31.36%
Hedge Fund
19.95%
Venture Capital
19.83%
Corporation
5.19%
Research Firm
3.87%
Private Equity
3.52%
Sovereign Wealth Fund
1.74%
Individual Investor
1.23%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
343
124.71M
120.47%
+8.83M
2025Q4
312
103.91M
106.70%
-4.37M
2025Q3
298
97.41M
100.29%
+9.46M
2025Q2
288
93.19M
110.15%
+12.20M
2025Q1
294
83.96M
99.59%
+456.78K
2024Q4
284
80.39M
113.18%
-3.73M
2024Q3
272
78.70M
112.04%
-2.29M
2024Q2
265
76.25M
113.03%
-1.57M
2024Q1
276
71.21M
105.62%
-1.02M
2023Q4
259
57.91M
108.09%
+1.21M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Nextech Invest, Ltd.
7.16M
7.35%
--
--
Sep 30, 2025
EcoR1 Capital, LLC
6.73M
6.91%
--
--
Sep 30, 2025
Viking Global Investors LP
6.57M
6.75%
--
--
Sep 30, 2025
VR Adviser, LLC
6.60M
6.77%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.54M
4.66%
+1.11M
+32.42%
Sep 30, 2025
Pfizer Inc
5.38M
5.52%
--
--
Sep 30, 2025
SR One Capital Management, LP
4.51M
4.64%
-100.45K
-2.18%
Sep 30, 2025
State Street Investment Management (US)
2.40M
2.47%
+771.82K
+47.29%
Sep 30, 2025
New Enterprise Associates (NEA)
4.12M
4.23%
--
--
Sep 30, 2025
Alkeon Capital Management LLC
3.75M
3.85%
--
--
Sep 30, 2025
View more

Related ETFs

Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Genomics Immunology and Healthcare ETF
1.12%
Virtus LifeSci Biotech Clinical Trials ETF
0.92%
Tema Oncology ETF
0.39%
State Street SPDR S&P Biotech ETF
0.28%
Optimize Strategy Index ETF
0.27%
iShares Health Innovation Active ETF
0.2%
Direxion Daily S&P Biotech Bull 3X Shares
0.17%
iShares Micro-Cap ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.13%
Invesco Nasdaq Biotechnology ETF
0.12%
View more
iShares Genomics Immunology and Healthcare ETF
Proportion1.12%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.92%
Tema Oncology ETF
Proportion0.39%
State Street SPDR S&P Biotech ETF
Proportion0.28%
Optimize Strategy Index ETF
Proportion0.27%
iShares Health Innovation Active ETF
Proportion0.2%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.17%
iShares Micro-Cap ETF
Proportion0.15%
ProShares Ultra Nasdaq Biotechnology
Proportion0.13%
Invesco Nasdaq Biotechnology ETF
Proportion0.12%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.